Altre lingue Azenta, Inc.

Azioni

AZTA

US1143401024

Biotecnologia

Mercato chiuso - Nasdaq Altri mercati azionari 21:00:00 11/03/2026			Variaz. 5gg	Var. 1 gen.
22,87 ^USD	+0,40%		-8,99%	-31,24%

10/03	Azenta, Inc., Uk Biocentre Limited - M&A Call
04/03	Azenta acquisisce UK Biocentre per 27,4 milioni di dollari	MT

Altre lingue

04/03	Azenta Acquires UK Biocentre for $27.4 Million
04/03	Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities
04/03	Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
24/02	Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
09/02	Azenta Teams Up With Frontier Space for Space-Based Scientific Experiments
09/02	Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
09/02	Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
04/02	Azenta Shares Drop After Fiscal Q1 Results
04/02	Azenta, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2025
04/02	Azenta, Inc. Reiterates Earnings Guidance for Full Year Fiscal 2026
04/02	Tranche Update on Azenta, Inc.'s Equity Buyback Plan announced on December 10, 2025.
04/02	Azenta Fiscal Q1 Non-GAAP Earnings Fall, Revenue Rises; Shares Down Pre-Bell
04/02	Earnings Flash (AZTA) Azenta, Inc. Reports Q1 Revenue $149.0M, vs. FactSet Est of $147.1M
04/02	Earnings Flash (AZTA) Azenta, Inc. Posts Q1 Adjusted EPS $0.09 per Share, vs. FactSet Est of $0.14
04/02	Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
02/02	Azenta, Inc. Announces Resignation of Alan P. Malus from Board of Directors and Member of Human Resources and Compensation Committee, Effective January 29, 2026
29/01	Gartner, Inc. Announces Board Appointments, Effective from January 29, 2026
21/01	Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
30/12	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L.
29/12	Azenta to Sell B Medical Systems Business
29/12	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
18/12	Azenta, Inc. Announces Directors Not Nominated for Re-Election
10/12	Health Care Up on Earnings Optimism - Health Care Roundup
10/12	Azenta authorizes $250 million share repurchase program
10/12	Azenta Board Approves $250 Million Stock Buyback Program